Stock Traders Buy Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX)

Forte Biosciences, Inc. (NASDAQ:FBRXGet Rating) saw some unusual options trading on Wednesday. Investors bought 30,205 call options on the stock. This represents an increase of approximately 1,663% compared to the typical daily volume of 1,713 call options.

NASDAQ FBRX opened at $1.40 on Thursday. The business has a 50 day simple moving average of $1.40 and a 200 day simple moving average of $2.03. Forte Biosciences has a one year low of $1.18 and a one year high of $7.26.

Several institutional investors have recently bought and sold shares of FBRX. BlackRock Inc. grew its position in shares of Forte Biosciences by 5.9% during the 4th quarter. BlackRock Inc. now owns 817,063 shares of the company’s stock worth $1,748,000 after buying an additional 45,337 shares during the period. Goldman Sachs Group Inc. grew its holdings in Forte Biosciences by 554.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 85,240 shares of the company’s stock worth $182,000 after purchasing an additional 72,206 shares during the period. Deutsche Bank AG increased its stake in Forte Biosciences by 683.0% in the fourth quarter. Deutsche Bank AG now owns 64,050 shares of the company’s stock valued at $137,000 after purchasing an additional 55,870 shares in the last quarter. Parametric Portfolio Associates LLC raised its holdings in shares of Forte Biosciences by 57.2% during the fourth quarter. Parametric Portfolio Associates LLC now owns 174,724 shares of the company’s stock valued at $374,000 after purchasing an additional 63,582 shares during the period. Finally, Squarepoint Ops LLC bought a new position in shares of Forte Biosciences during the 4th quarter worth about $28,000. Hedge funds and other institutional investors own 36.29% of the company’s stock.

Forte Biosciences Company Profile (Get Rating)

Forte Biosciences, Inc operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Read More

Receive News & Ratings for Forte Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forte Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.